Ajooni Biotech Limited — Board Meeting, 03-01-2025: Outcome of Board Meeting

The Board of Directors of Ajooni Biotech Limited has approved several key resolutions. They have amended the Articles of Association to enable future security issues in various forms, and increased the Authorized Share Capital from ₹40 Cr to ₹50 Cr. Additionally, the Board approved the issuance of up to 5 Cr convertible warrants at ₹9 per warrant, potentially raising ₹45 Cr, subject to member approval. They also appointed Mr. Ishtneet Bhatia as an Independent Director and scheduled an Extra Ordinary General Meeting for further discussions and approvals on these matters.